Gossamer Bio Inc. (NASDAQ: GOSS) reported Q2 EPS of ($0.74), $0.18 worse than the analyst estimate of ($0.56).“Over the last ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE